Testing a New Treatment for Skin and Joint Problems in Psoriasis Patients

This trial is testing a medication called Secukinumab to see if it can help people with moderate to severe psoriasis who also have very early signs of joint inflammation (called enthesitis) that they may not even feel yet. Researchers will use ultrasound with special imaging to detect and monitor these early joint changes as participants take the medication over time. The goal is to understand whether treating the skin condition early can also prevent joint problems from developing.

Psoriasis can lead to joint damage even before patients notice pain or swelling, and catching this early might prevent more serious problems later. This study wants to see if this medication can stop joint inflammation in its earliest stages, before it becomes a bigger health issue.